Topic

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Articles

FDA’s approval rate slowed, but the US agency is still ahead of its international counterparts in green-lighting new drugs for market.

US Maintains Lead in Drug Development Despite Fewer Approvals in 2019

Agnes Shanley is senior editor of Pharmaceutical Technology.

Antimicrobial resistance is now the third leading cause of death in the US. As developers continue to leave an unprofitable market, legislation and new reimbursement models propose to stimulate development of new antibiotics.

Restoring the World's Antibiotic Pipeline

Researchers in China are playing a role in advancing gene therapy development.

China Invests in Gene Therapy Research

At INTERPHEX 2019, CEO Richard Johnson highlighted the importance of PDA’s new Asian business unit and outlined the organization’s plans. Data integrity guidance for manufacturing and quality systems will be published by the end of the year, as efforts move into big data and artificial intelligence.

PDA Strengthens its Global Presence

The US and pharmerging markets will drive growth in drug spending; number of approvals to increase.

Global Medicine Spending to Top $1.5 Trillion by 2023

New analysis from the OECD highlights that spending just a couple of dollars per person could help prevent deaths from antimicrobial resistance.

New Report Claims that a Few Dollars More Per Person Could Stop AMR

CPhI Korea to feature zone for finished dosage formulation drug products.

Generics Drive Finished Drug Market Growth in Korea

WuXi STA supported the development of hepatitis drug through marketing authorization holder pilot program.

CFDA Approves Drug Developed with CDMO Support

Intelligent manufacturing and environmental policies are key trends at P-MEC 2018.

Domestic Pharma Industry Drives Machinery Demands at P-MEC China

The India Expo Mart in Delhi will host CPhI and P-MEC India with expected attendance of 50,000.

Global Perspectives